The action, filed on Monday in the United States District Court for the District of Delaware, targets Annora Pharma Private Limited and associated entities, which have filed an Abbreviated New ...

The action, filed on Monday in the United States District Court for the District of Delaware, targets Annora Pharma Private Limited and associated entities, which have filed an Abbreviated New Drug ...

Annora Pharma’s ANDA Challenge to Orladeyo’s Patents In January 2025, Annora Pharma filed an ANDA with the FDA seeking approval to market a generic version of Orladeyo. Annora is challenging ...

OKYO Pharma (OKYO) announces the filing of its application for Fast Track designation, FTD, with the U.S. Food and Drug Administration, FDA, for urcosimod for the treatment of neuropathic corneal ...

In a report released today, Marc Frahm from TD Cowen maintained a Buy rating on Inozyme Pharma (INZY – Research Report). The company’s shares opened today at $1.14. Effectively assess a stock ...

Innocan Pharma Ltd. Each Warrant is exercisable into one Common Share at a price of CAD$0.26 for a period of four (4) years from the date of issuance. Innocan intends to use the proceeds of the ...

Feb 19 (Reuters) - An index of Indian pharmaceutical company shares (.NIPHARM), opens new tab slid 2% to its lowest level in seven months on Wednesday after U.S. President Donald Trump said he ...

Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles Annora Spence is a British Postwar & Contemporary artist who was born in 1963.

Like Queen Elizabeth, she loves horses and a great tiara moment. Meghan Markle's refreshed lifestyle brand has a logo with a meaningful symbol. On Feb. 18, the Duchess of Sussex announced that she ...

HERZLIYA, Israel and CALGARY, AB, March 7, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it has closed its ...

In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against the other stocks. The stock market may have registered losses on Friday ...